Proton pump inhibitors and acute interstitial nephritis.

Drug-induced acute interstitial nephritis. Nat Rev Nephrol (2010) 1.74

A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use. Kidney Int (2014) 1.30

Proton pump inhibitor-induced acute interstitial nephritis. Br J Clin Pharmacol (2007) 1.29

Proton pump inhibitors and acute kidney injury: a nested case-control study. BMC Nephrol (2013) 1.23

Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort study. CMAJ Open (2015) 1.07

Pantoprazole-induced acute interstitial nephritis. CMAJ (2012) 1.02

Acid peptic diseases: pharmacological approach to treatment. Expert Rev Clin Pharmacol (2009) 1.00

Adherence to best practice guidelines in dyspepsia: a survey comparing dyspepsia experts, community gastroenterologists and primary-care providers. Aliment Pharmacol Ther (2009) 0.98

Insights into the future of gastric acid suppression. Nat Rev Gastroenterol Hepatol (2009) 0.98

Proton pump inhibitors: Are we still prescribing them without valid indications? Australas Med J (2014) 0.85

Evaluation of costs accrued through inadvertent continuation of hospital-initiated proton pump inhibitor therapy for stress ulcer prophylaxis beyond hospital discharge: a retrospective chart review. Ther Clin Risk Manag (2015) 0.80

Association Between the Use of Proton Pump Inhibitors and the Risk of ESRD in Renal Diseases: A Population-Based, Case-Control Study. Medicine (Baltimore) (2016) 0.79

Acute interstitial nephritis due to proton pump inhibitors. Indian J Nephrol (2013) 0.78

Proton pump inhibitors are associated with increased risk of development of chronic kidney disease. BMC Nephrol (2016) 0.77

Proton Pump Inhibitors and CKD. J Am Soc Nephrol (2016) 0.77

Proton pump inhibitors. Clin Gastroenterol Hepatol (2006) 0.75

Gastroprotective mechanism of Paederia foetida Linn. (Rubiaceae)--a popular edible plant used by the tribal community of North-East India. BMC Complement Altern Med (2015) 0.75

Drug-Induced Kidney Injury in the Elderly. Drugs Aging (2017) 0.75

A Retrospective Study to Assess the Effect of Proton Pump Inhibitors on Renal Profile in a South Indian Hospital. J Clin Diagn Res (2017) 0.75

Proton-pump inhibitors: understanding the complications and risks. Nat Rev Gastroenterol Hepatol (2017) 0.75

Cancer incidence before and after kidney transplantation. JAMA (2006) 4.77

Sodium zirconium cyclosilicate in hyperkalemia. N Engl J Med (2014) 4.13

Acute rejection, T-cell-depleting antibodies, and cancer after transplantation. Transplantation (2014) 3.40

Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study. J Am Soc Nephrol (2005) 2.91

Sirolimus is associated with new-onset diabetes in kidney transplant recipients. J Am Soc Nephrol (2008) 2.59

Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights. Kidney Int (2012) 2.38

Antibiotics for acute pyelonephritis in children. Cochrane Database Syst Rev (2014) 2.17

Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials. Lancet (2005) 2.09

A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis. Am J Kidney Dis (2008) 2.02

Dialysis modality preference of patients with CKD and family caregivers: a discrete-choice study. Am J Kidney Dis (2012) 1.97

Diagnosis and management of iron deficiency anaemia: a clinical update. Med J Aust (2010) 1.78

Life-threatening hypokalaemia associated with ibuprofen-induced renal tubular acidosis. Med J Aust (2011) 1.58

Association of CKD and cancer risk in older people. J Am Soc Nephrol (2009) 1.57

Time on dialysis and cancer risk after kidney transplantation. Transplantation (2013) 1.53

Cardiac testing for coronary artery disease in potential kidney transplant recipients. Cochrane Database Syst Rev (2011) 1.52

A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients. Nephrol Dial Transplant (2010) 1.52

The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transplant (2009) 1.48

Interventions for the symptoms and signs resulting from jellyfish stings. Cochrane Database Syst Rev (2013) 1.46

Long-term cancer risk of immunosuppressive regimens after kidney transplantation. J Am Soc Nephrol (2010) 1.45

Prognostic value of cardiac tests in potential kidney transplant recipients: a systematic review. Transplantation (2015) 1.43

Factors influencing patient choice of dialysis versus conservative care to treat end-stage kidney disease. CMAJ (2012) 1.43

Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities. PLoS One (2012) 1.42

European Renal Best Practice (ERBP) Guideline development methodology: towards the best possible guidelines. Nephrol Dial Transplant (2013) 1.40

Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Cochrane Database Syst Rev (2012) 1.39

Steroid avoidance or withdrawal for kidney transplant recipients. Cochrane Database Syst Rev (2016) 1.39

Fistula dysfunction secondary to a subcutaneous myelomatous deposit. Nephrol Dial Transplant (2005) 1.39

How long should treatments be continued? BMJ (2010) 1.37

Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials. J Antimicrob Chemother (2006) 1.34

Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database Syst Rev (2013) 1.30

Implementing iron management clinical practice guidelines in patients with chronic kidney disease having dialysis. Med J Aust (2006) 1.28

Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Circulation (2006) 1.28

Safety, immunogenicity and efficacy of subcutaneous biosimilar epoetin-α (HX575) in non-dialysis patients with renal anemia: a multi-center, randomized, double-blind study. Clin Nephrol (2012) 1.26

Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation. Blood (2009) 1.23

How to write a Cochrane systematic review. Nephrology (Carlton) (2010) 1.21

Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study. BMJ (2010) 1.18

Trial registration and declaration of registration by authors of randomized controlled trials. Transplantation (2011) 1.14

Effect of early correction of anemia on the progression of CKD. Am J Kidney Dis (2006) 1.12

Characteristics of dialysis important to patients and family caregivers: a mixed methods approach. Nephrol Dial Transplant (2011) 1.08

Antiplatelet agents for chronic kidney disease. Cochrane Database Syst Rev (2013) 1.08

The role of thiazolidinediones in non-alcoholic steatohepatitis - a systematic review and meta analysis. J Hepatol (2011) 1.07

Cancer in the transplant recipient. Cold Spring Harb Perspect Med (2013) 1.06

Cutaneous melanoma is related to immune suppression in kidney transplant recipients. Cancer Epidemiol Biomarkers Prev (2009) 1.05

Antioxidants for chronic kidney disease. Cochrane Database Syst Rev (2012) 1.02

Probiotics for patients with hepatic encephalopathy. Cochrane Database Syst Rev (2011) 1.01

Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database Syst Rev (2010) 1.00

Belatacept for kidney transplant recipients. Cochrane Database Syst Rev (2014) 0.99

Treatment for lupus nephritis. Cochrane Database Syst Rev (2012) 0.98

Patients who plan for conservative care rather than dialysis: a national observational study in Australia. Am J Kidney Dis (2011) 0.98

Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev (2013) 0.97

Meta-analyses in prevention and treatment of urinary tract infections. Infect Dis Clin North Am (2009) 0.97

Patient INformation about Options for Treatment (PINOT): a prospective national study of information given to incident CKD Stage 5 patients. Nephrol Dial Transplant (2010) 0.97

Antidepressants for depression in stage 3-5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP). Nephrol Dial Transplant (2012) 0.97

Longitudinal analysis of performance of estimated glomerular filtration rate as renal function declines in chronic kidney disease. Nephrol Dial Transplant (2008) 0.96

Diagnosis and treatment of hyponatremia: a systematic review of clinical practice guidelines and consensus statements. BMC Med (2014) 0.95

Development, prevention, and potential reversal of left ventricular hypertrophy in chronic kidney disease. J Am Soc Nephrol (2004) 0.93

Antihypertensives for kidney transplant recipients: systematic review and meta-analysis of randomized controlled trials. Transplantation (2009) 0.92

No excess risk of follicular lymphoma in kidney transplant and HIV-related immunodeficiency. Int J Cancer (2010) 0.92

Immunosuppression and other risk factors for lip cancer after kidney transplantation. Cancer Epidemiol Biomarkers Prev (2009) 0.92

Induction and maintenance treatment of proliferative lupus nephritis: a meta-analysis of randomized controlled trials. Am J Kidney Dis (2012) 0.90

The FIND-CKD study--a randomized controlled trial of intravenous iron versus oral iron in non-dialysis chronic kidney disease patients: background and rationale. Nephrol Dial Transplant (2013) 0.90

Rabeprazole-induced acute interstitial nephritis. Nephrology (Carlton) (2005) 0.87

The perspectives of kidney transplant recipients on medicine taking: a systematic review of qualitative studies. Nephrol Dial Transplant (2010) 0.86

Tests for latent tuberculosis in people with ESRD: a systematic review. Am J Kidney Dis (2012) 0.86

Systematic review of randomized controlled trial quality in pediatric kidney transplantation. Pediatr Nephrol (2010) 0.85

Increased incidence of squamous cell carcinoma of eye after kidney transplantation. J Natl Cancer Inst (2007) 0.84

Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev (2013) 0.83

Current trends in immunosuppression following organ transplantation in children. Curr Opin Organ Transplant (2013) 0.83

Screening for renal cancer in recipients of kidney transplants. Nephrol Dial Transplant (2010) 0.83

Cardiac testing for coronary artery disease in potential kidney transplant recipients: a systematic review of test accuracy studies. Am J Kidney Dis (2011) 0.82

Reported cancer screening practices of nephrologists: results from a national survey. Nephrol Dial Transplant (2009) 0.82

Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trial. Nephrol Dial Transplant (2009) 0.81

The cost-effectiveness of induction immunosuppression in kidney transplantation. Nephrol Dial Transplant (2009) 0.81

How Qualitative Research Informs Clinical and Policy Decision Making in Transplantation: A Review. Transplantation (2016) 0.81

Patient information about options for treatment: Methods of a national audit of information provision in chronic kidney disease. Nephrology (Carlton) (2010) 0.80

Steroid avoidance or withdrawal for pancreas and pancreas with kidney transplant recipients. Cochrane Database Syst Rev (2014) 0.80

Assessment of the bioequivalence of a generic cyclosporine A by a randomized controlled trial in stable renal recipients. Transplantation (2006) 0.80

The Seville expert workshop for progress in posttransplant lymphoproliferative disorders. Transplantation (2012) 0.80

Antihypertensive treatment for kidney transplant recipients. Cochrane Database Syst Rev (2009) 0.79

Medical device regulation in Australia: safe and effective? Med J Aust (2012) 0.79

How to get the most from the medical literature: keeping up to date in nephrology. Nephrology (Carlton) (2010) 0.79

Treatments to slow progression of autosomal dominant polycystic kidney disease: systematic review and meta-analysis of randomized trials. Nephrology (Carlton) (2014) 0.79

Hypercalcaemia as a prodromal feature of indolent Pneumocystis jivorecii after renal transplantation. Nephrol Dial Transplant (2011) 0.79

Epoetin treatment: what are the arguments to expect a beneficial effect on renal disease progression? Nephrol Dial Transplant (2002) 0.78

Test performance of faecal occult blood testing for the detection of bowel cancer in people with chronic kidney disease (DETECT) protocol. BMC Public Health (2011) 0.78

Diagnostic test studies in nephrology: quantity, quality, and scope. Am J Kidney Dis (2011) 0.78

Epoetin trials: randomised controlled trials don't always mimic observational data. Nephrol Dial Transplant (2007) 0.78

Angiotensin-Converting Enzyme Inhibitors-Beneficial Effects Seen in Many Patient Groups May Not Extend to Kidney Transplant Recipients. Transplantation (2016) 0.77

Diagnostic accuracy of blood qualitative nucleic acid testing for polyomavirus-associated nephropathy in kidney recipients. Nephrology (Carlton) (2009) 0.77

Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients. Cochrane Database Syst Rev (2015) 0.77

Systematic reviews of surgical procedures in children: quantity, coverage and quality. J Paediatr Child Health (2013) 0.76

ACEIs for cardiovascular risk reduction--have we taken our eye off the ball? Aust Fam Physician (2013) 0.76

The case of azathioprine versus mycophenolate. Do different drugs really cause different transplant outcomes? Transplantation (2009) 0.75

Chronic kidney disease, anemia, and epoetin. N Engl J Med (2007) 0.75

The importance of quality appraisal in meta-analysis. Clin Gastroenterol Hepatol (2012) 0.75

Proton pump inhibitors: indigestion for nephrologists! Nephrology (Carlton) (2006) 0.75

Expanding the evidence base in transplantation: more and better randomized trials, and extending the value of observational data. Transplantation (2008) 0.75

Peginesatide for maintenance treatment of anemia in hemodialysis and nondialysis patients previously treated with darbepoetin alfa. Clin J Am Soc Nephrol (2012) 0.75

Understanding epoetin use: databases or clinical trials? Nephrology (Carlton) (2007) 0.75

Erythropoiesis-stimulating agents for anaemia in chronic kidney disease: Are they all the same? Cochrane Database Syst Rev (2014) 0.75